A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

Autor: Leslie, Kimberly K., Sill, Michael W., Fischer, Edgar, Darcy, Kathleen M., Mannel, Robert S., Tewari, Krishnansu S., Hanjani, Parviz, Wilken, Jason A., Baron, Andre T., Godwin, Andrew K., Schilder, Russell J., Singh, Meenakshi, Maihle, Nita J.
Zdroj: In Gynecologic Oncology June 2013 129(3):486-494
Databáze: ScienceDirect